Home Applications 219685 Application 219685
Type NDA
Sponsor GENZYME CORP Application Products# Product, Drug, Ingredient table Product Drug Ingredient Form Strength Reference drug Reference standard 001 WAYRILZ RILZABRUTINIB TABLET;ORAL 400MG Yes Yes
Source provenance: Browse the complete Orange Book source catalog · source snapshot 1 .
Orange Book products# Current product rows page 1 of 1 · 1 matching rows.
Application-product, Trade name, Ingredient table Application-product Trade name Ingredient Strength Dosage form / route TE codes RLD / RS Approval date N219685-001 WAYRILZ RILZABRUTINIB 400MG TABLET / ORAL RLD, RS 2025-08-29
Orange Book patents# Current patent rows page 1 of 1 · 7 matching rows.
Application-product, Patent, Expiration table Application-product Patent Expiration Use code Coverage / status Submission date N219685-001 9580427 2033-03-01 Drug substance, Drug product 2025-09-25 N219685-001 8940744 2033-09-06 U-4270 Drug substance, Drug product 2025-09-25 N219685-001 9266895 2033-09-06 U-4268 Drug substance, Drug product 2025-09-25 N219685-001 9994576 2033-09-06 U-4268 Drug substance, Drug product 2025-09-25 N219685-001 9994576 2033-09-06 U-4269 Drug substance, Drug product 2025-09-25 N219685-001 12178818 2040-10-13 U-4267 2025-09-25 N219685-001 11708370 2041-02-20 Drug substance 2025-09-25
Orange Book exclusivity# Current exclusivity rows page 1 of 1 · 2 matching rows.
Application-product, Exclusivity code, Expiration table Application-product Exclusivity code Expiration N219685-001 NCE 2030-08-29 N219685-001 ODE-552 2032-08-29
Observed Orange Book product history# Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
Captured, Edition, Application-product table Captured Edition Application-product Trade name Strength Dosage form / route Product TE source text RLD / RS Approval date Source SHA-256 2026-02-19 14:30 UTC 2026-02 N219685-001 WAYRILZ 400MG TABLET / ORAL RLD, RS 2025-08-29 011fe1cb6892…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N219685-001 WAYRILZ 400MG TABLET / ORAL RLD, RS 2025-08-29 31067a03dcf5…2026-07-26 02:55 UTC · 3 captures of this ZIP 2026-06 N219685-001 WAYRILZ 400MG TABLET / ORAL RLD, RS 2025-08-29 a50c72e98297…
Observed Orange Book patent history# Captured, Edition, Application-product table Captured Edition Application-product Patent Expiration Use code Coverage / status Submission date Source SHA-256 2026-02-19 14:30 UTC 2026-02 N219685-001 9580427 2033-03-01 Drug substance, Drug product 2025-09-25 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N219685-001 8940744 2033-09-06 U-4270 Drug substance, Drug product 2025-09-25 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N219685-001 9266895 2033-09-06 U-4268 Drug substance, Drug product 2025-09-25 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N219685-001 9994576 2033-09-06 U-4268 Drug substance, Drug product 2025-09-25 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N219685-001 9994576 2033-09-06 U-4269 Drug substance, Drug product 2025-09-25 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N219685-001 12178818 2040-10-13 U-4267 2025-09-25 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N219685-001 11708370 2041-02-20 Drug substance 2025-09-25 011fe1cb6892…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N219685-001 9580427 2033-03-01 Drug substance, Drug product 2025-09-25 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N219685-001 8940744 2033-09-06 U-4270 Drug substance, Drug product 2025-09-25 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N219685-001 9266895 2033-09-06 U-4268 Drug substance, Drug product 2025-09-25 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N219685-001 9994576 2033-09-06 U-4268 Drug substance, Drug product 2025-09-25 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N219685-001 9994576 2033-09-06 U-4269 Drug substance, Drug product 2025-09-25 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N219685-001 12178818 2040-10-13 U-4267 2025-09-25 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N219685-001 11708370 2041-02-20 Drug substance 2025-09-25 31067a03dcf5…2026-07-26 02:55 UTC · 3 captures of this ZIP 2026-06 N219685-001 9580427 2033-03-01 Drug substance, Drug product 2025-09-25 a50c72e98297…2026-07-26 02:55 UTC · 3 captures of this ZIP 2026-06 N219685-001 8940744 2033-09-06 U-4270 Drug substance, Drug product 2025-09-25 a50c72e98297…2026-07-26 02:55 UTC · 3 captures of this ZIP 2026-06 N219685-001 9266895 2033-09-06 U-4268 Drug substance, Drug product 2025-09-25 a50c72e98297…2026-07-26 02:55 UTC · 3 captures of this ZIP 2026-06 N219685-001 9994576 2033-09-06 U-4268 Drug substance, Drug product 2025-09-25 a50c72e98297…2026-07-26 02:55 UTC · 3 captures of this ZIP 2026-06 N219685-001 9994576 2033-09-06 U-4269 Drug substance, Drug product 2025-09-25 a50c72e98297…2026-07-26 02:55 UTC · 3 captures of this ZIP 2026-06 N219685-001 12178818 2040-10-13 U-4267 2025-09-25 a50c72e98297…2026-07-26 02:55 UTC · 3 captures of this ZIP 2026-06 N219685-001 11708370 2041-02-20 Drug substance 2025-09-25 a50c72e98297…
Observed Orange Book exclusivity history# Captured, Edition, Application-product table Captured Edition Application-product Exclusivity code Expiration Source SHA-256 2026-02-19 14:30 UTC 2026-02 N219685-001 NCE 2030-08-29 011fe1cb6892…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N219685-001 NCE 2030-08-29 31067a03dcf5…2026-07-26 02:55 UTC · 3 captures of this ZIP 2026-06 N219685-001 NCE 2030-08-29 a50c72e98297…2026-07-26 02:55 UTC · 3 captures of this ZIP 2026-06 N219685-001 ODE-552 2032-08-29 a50c72e98297…
openFDA label cross-check# OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
Matched openFDA labels page 1 of 1 · 1 matching rows.
Brand, Generic, Manufacturer table Brand Generic Manufacturer SPL set ID Effective date Available safety fields Join WAYRILZ RILZABRUTINIB Genzyme Corporation 95ffd367-9b0c-4f75-8487-5d8f3c0a5ad0 2025-08-26 Warnings, Adverse reactions Exact identifier application applno (NDA): 219685 application number: NDA219685
Documents# Document, Submission type, Date table Document Submission type Date 83572 ORIG 2025-09-29 83270 ORIG 2025-09-03 83243 ORIG 2025-09-02